Showing results (41-50 of 130) with videos related to
Sort By:
Pageof 13
International Journal of Impotence Research|October 5, 2022
Factors associated with postoperative urinary retention in patients undergoing penile prosthesis implantationJohnathan A Drevik, Zafardjan Dalimov, Jacob Lucas, et al.Urology|October 18, 2024
Persistent Opioid Use Following Artificial Urinary Sphincter Placement: A Large Claims Database AnalysisRyan J Davis, Marissa Maas, David Ginsberg, et al.Urology|June 5, 2016
Unexpected High Rates of Angiography and Angioembolization for Isolated Low-grade Renal Trauma: Results From a Large, Statewide, Trauma DatabaseRonak A Gor, Brett A Styskel, Tianyu Li, et al.Urology Case Reports|June 13, 2020
Multidisciplinary management of adult cloacal exstrophy complications: A challenging case of nephrolithiasis and abdominal wall extrusion of a catheterizable ileal pouchSarah S Christianson, Eric Ghiraldi, Justin Friedlander, et al.International Journal of Impotence Research|April 1, 2024
Penoscrotal inflatable penile prosthesis recipients often fully recover from pain at two weeks following placementAlice Xiang, Avery E Braun, Chrystal Chang, et al.Urology|December 3, 2014
Dorsal plication without degloving is safe and effective for correcting ventral penile deformitiesPaul H Chung, Timothy J Tausch, Jay Simhan, et al.Urology|November 30, 2014
High submuscular placement of urologic prosthetic balloons and reservoirs: 2-year experience and patient-reported outcomesPaul H Chung, Allen F Morey, Timothy J Tausch, et al.International Journal of Impotence Research|May 8, 2023
Defining the incidence and management of postoperative scrotal hematoma after primary and complex three-piece inflatable penile prosthesis surgeryAvery E Braun, Daniel Swerdloff, Architha Sudhakar, et al.Current Urology Reports|February 3, 2021
Pain Management Strategies in Contemporary Penile Implant RecipientsJeffrey L Ellis, Jessica J Pryor, Melissa Mendez, et al.The Canadian Journal of Urology|August 23, 2011
Are all multi-targeted tyrosine kinase inhibitors created equal? An in vitro study of sunitinib and pazopanib in renal cell carcinoma cell linesDaniel Canter, Alexander Kutikov, Konstantin Golovine, et al.Pageof 13